SC 13D

Company

KalVista Pharmaceuticals, Inc.

Filed

October 20, 2017

Accession Number

0001193125-17-315435

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →